Longitudinal hemodynamics of transcatheter and surgical aortic valves in the PARTNER Trial

JAMA Cardiology

Volumn 2, Issue 11, 2017, Pages 1197-1206

  Douglas, Pamela S ^a   Leon, Martin B ^a,b   Mack, Michael J ^c   Svensson, Lars G ^d   Webb, John G ^e   Hahn, Rebecca T ^a,b   Pibarot, Philippe ^f   Weissman, Neil J ^g   Miller, D Craig ^g,h   Kapadia, Samir ^d   Herrmann, Howard C ⁱ   Kodali, Susheel K ^b   Makkar, Raj R ^j   Thourani, Vinod H ^k   Lerakis, Stamatios ^k   Lowry, Ashley M ^d   Rajeswaran, Jeevanantham ^d   Finn, Matthew T ^b   Alu, Maria C ^b   Smith, Craig R ^b   Blackstone, Eugene H ^d   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f LAVAL UNIVERSITY   (Canada)

^g WASHINGTON HOSPITAL CENTER   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j CEDARS SINAI MEDICAL CENTER   (United States)

^k EMORY UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALL CAUSE MORTALITY; AORTIC REGURGITATION; AORTIC VALVE MEAN GRADIENT; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PARAVALVULAR LEAK; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVE DETERIORATION; VELOCITY; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOPROSTHESIS; BLOOD FLOW VELOCITY; DIAGNOSTIC IMAGING; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMODYNAMICS; LONGITUDINAL STUDY; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOPROSTHESIS; BLOOD FLOW VELOCITY; ECHOCARDIOGRAPHY; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; LONGITUDINAL STUDIES; MALE; REOPERATION; STROKE VOLUME; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 85034630112     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2017.3306     Document Type: Article

References (28)

1. Mack MJ, Leon MB, Smith CR, et al; PARTNER 1 Trial Investigators. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385 (9986):2477-2484.
2. Kapadia SR, Leon MB, Makkar RR, et al; PARTNER Trial Investigators. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385 (9986):2485-2491.
3. Deeb GM, Reardon MJ, Chetcuti S, et al; CoreValve US Clinical Investigators. 3-Year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67(22):2565-2574.
4. Brennan JM, Edwards FH, Zhao Y, et al; DEcIDE AVR (Developing Evidence to Inform Decisions about Effectiveness–Aortic Valve Replacement) Research Team. Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. Circulation. 2013;127(16): 1647-1655.
5. Zhao DF, Seco M, Wu JJ, et al. Mechanical versus bioprosthetic aortic valve replacement in middle-aged adults: a systematic review and meta-analysis. Ann Thorac Surg. 2016;102(1):315-327.
6. Grover FL, Vemulapalli S, Carroll JD, et al; STS/ACC TVT Registry. 2016 annual report of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Ann Thorac Surg. 2017;103(3):1021-1035.
7. Makkar RR, Fontana G, Jilaihawi H, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373(21):2015-2024.
8. Del Trigo M, Muñoz-Garcia AJ, Wijeysundera HC, et al. Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. J Am Coll Cardiol. 2016;67(6):644-655.
9. Dangas GD, Weitz JI, Giustino G, Makkar R, Mehran R. Prosthetic heart valve thrombosis. J Am Coll Cardiol. 2016;68(24):2670-2689.
10. Fearon WF, Kodali S, Doshi D, et al; PARTNER Trial Investigators. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry. JACC Cardiovasc Interv. 2014;7(11):1245-1251.
11. Dewey TM, Bowers B, Thourani VH, et al. Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. Ann Thorac Surg. 2013;96(6):2083-2089.
12. Leon MB, Smith CR, Mack M, et al; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363 (17):1597-1607.
13. Smith CR, Leon MB, Mack MJ, et al; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-2198.
14. Douglas PS, DeCara JM, Devereux RB, et al; American Society of Echocardiography Standards; American College of Cardiology Foundation. Echocardiographic imaging in clinical trials: American Society of Echocardiography Standards for echocardiography core laboratories: endorsed by the American College of Cardiology Foundation. J Am Soc Echocardiogr. 2009;22(7):755-765.
15. Douglas PS, Waugh RA, Bloomfield G, et al. Implementation of echocardiography core laboratory best practices: a case study of the PARTNER I trial. J Am Soc Echocardiogr. 2013;26(4): 348-358.e3.
16. Rajeswaran J, Blackstone EH. A multiphase non-linear mixed effects model: an application to spirometry after lung transplantation [published online 2014]. Stat Methods Med Res. doi:10.1177 /0962280214537255
17. Diggle PJ, Heagerty P, Liang KY, Zeger SL. Analysis of Longitudinal Data. 2nd ed. New York, NY: Oxford University Press; 2002.
18. Blackstone EH. Breaking down barriers: helpful breakthrough statistical methods you need to understand better. J Thorac Cardiovasc Surg. 2001; 122(3):430-439.
19. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York, NY: Chapman and Hall/CRC; 1998.
20. Verneke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. New York, NY: Springer-Verlag; 2001.
21. Kappetein AP, Head SJ, Généreux P, et al; Valve Academic Research Consortium (VARC)-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 2012;42(5): S45-S60.
22. Dvir D, Webb JG, Bleiziffer S, et al; Valve-in-Valve International Data Registry Investigators. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014;312(2):162-170.
23. Daubert MA, Weissman NJ, Hahn RT, et al. Long-term valve performance of TAVR and SAVR: a report from the PARTNER I Trial. JACC Cardiovasc Imaging. 2016;S1936-878X(16)30895-6.
24. Szeto WY, Svensson LG, Rajeswaran J, et al; Placement of Aortic Transcatheter Valves Trial Investigators. Appropriate patient selection or health care rationing? lessons from surgical aortic valve replacement in the Placement of Aortic Transcatheter Valves I trial. J Thorac Cardiovasc Surg. 2015;150(3):557-568.e11.
25. Asch FM, Heimansohn D, Doyle D, et al. Mitroflow aortic bioprosthesis 5-year follow-up: North American prospective multicenter study. Ann Thorac Surg. 2012;94(4):1198-1203.
26. Goldman S, Cheung A, Bavaria JE, Petracek MR, Groh MA, Schaff HV. Midterm, multicenter clinical and hemodynamic results for the Trifecta aortic pericardial valve. J Thorac Cardiovasc Surg. 2017;153(3):561-569.e2.
27. Egbe AC, Pislaru SV, Pellikka PA, et al. Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors. J Am Coll Cardiol. 2015;66(21):2285-2294.
28. Kodali S, Pibarot P, Douglas PS, et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J. 2015;36(7): 449-456.